FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043966544> ?p ?o ?g. }

• W2043966544 endingPage "1771" @default.
• W2043966544 startingPage "1765" @default.
• W2043966544 abstract "Abstract BACKGROUND In this report, the authors present the results from a study of patients with unresectable oropharyngeal squamous cell carcinomas who were treated on a protocol of hyperfractionated radiation and high‐dose intraarterial cisplatin (HYPERRADPLAT) at the University of Kentucky. METHODS The study was designed as a prospective, single‐armed case series that was conducted in the setting of a single, academic, tertiary referral center. The patient cohort consisted of 24 previously untreated patients who were diagnosed with unresectable oropharyngeal carcinoma and were treated on the HYPERRADPLAT regimen, which included hyperfractionated external beam radiotherapy (1.2 grays [Gy] twice daily) was given for 5 weeks (60 Gy) followed by high‐dose intraarterial cisplatin (150 mg/m 2 ) and sodium thiosulfate. Shrinking “large‐field” portals were started on Week 6 and finished on Week 7 with a cumulative dose of 76.8–81.6 Gy. The main outcome measures of the study were the primary and neck response rates, the 2‐year and 5‐year overall survival and disease‐specific survival rates, and acute and late treatment morbidity. RESULTS The median follow‐up was 77 months. Complete response rates at the primary and regional lymph nodes were both 88%. The 2‐year overall survival and disease‐specific survival rates were 57% and 68%, respectively; whereas the 5‐year overall survival and disease‐specific survival rates were 33% and 42%, respectively. Two patients had Grade 4 mucosal toxicity, and no patient experienced neurologic or significant hematologic toxicities. Within 1 year of treatment, 58% of patients had used a feeding tube. CONCLUSIONS The HYPERRADPLAT regimen produced excellent response rates and overall survival rates comparable to those achieved by patients who had unresectable oropharyngeal carcinomas. Tolerance of the therapy was good, and further studies using HYPERRADPLAT with induction therapy may improve outcomes further in this subset of patients with unfavorable disease. Cancer 2005. © 2005 American Cancer Society." @default.
• W2043966544 created "2016-06-24" @default.
• W2043966544 creator A5013997983 @default.
• W2043966544 creator A5017069200 @default.
• W2043966544 creator A5017246928 @default.
• W2043966544 creator A5026925016 @default.
• W2043966544 creator A5030064179 @default.
• W2043966544 creator A5034195468 @default.
• W2043966544 creator A5055132792 @default.
• W2043966544 creator A5057167506 @default.
• W2043966544 creator A5070311654 @default.
• W2043966544 creator A5070621756 @default.
• W2043966544 creator A5079124490 @default.
• W2043966544 date "2005-10-03" @default.
• W2043966544 modified "2023-10-17" @default.
• W2043966544 title "Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma" @default.
• W2043966544 cites W1784479792 @default.
• W2043966544 cites W1951315939 @default.
• W2043966544 cites W1953373541 @default.
• W2043966544 cites W1972010477 @default.
• W2043966544 cites W1976774278 @default.
• W2043966544 cites W1979164573 @default.
• W2043966544 cites W2002414921 @default.
• W2043966544 cites W2010402293 @default.
• W2043966544 cites W2018757640 @default.
• W2043966544 cites W2022232109 @default.
• W2043966544 cites W2027999349 @default.
• W2043966544 cites W2038864978 @default.
• W2043966544 cites W2053469511 @default.
• W2043966544 cites W2067551303 @default.
• W2043966544 cites W2092845422 @default.
• W2043966544 cites W2133040473 @default.
• W2043966544 cites W2139554459 @default.
• W2043966544 cites W2144699072 @default.
• W2043966544 cites W2145943661 @default.
• W2043966544 cites W2151415400 @default.
• W2043966544 cites W2155019837 @default.
• W2043966544 cites W2265151752 @default.
• W2043966544 cites W2317162156 @default.
• W2043966544 cites W2562414697 @default.
• W2043966544 doi "https://doi.org/10.1002/cncr.21368" @default.
• W2043966544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16149090" @default.
• W2043966544 hasPublicationYear "2005" @default.
• W2043966544 type Work @default.
• W2043966544 sameAs 2043966544 @default.
• W2043966544 citedByCount "20" @default.
• W2043966544 countsByYear W20439665442012 @default.
• W2043966544 countsByYear W20439665442013 @default.
• W2043966544 countsByYear W20439665442014 @default.
• W2043966544 countsByYear W20439665442016 @default.
• W2043966544 countsByYear W20439665442018 @default.
• W2043966544 countsByYear W20439665442021 @default.
• W2043966544 countsByYear W20439665442022 @default.
• W2043966544 crossrefType "journal-article" @default.
• W2043966544 hasAuthorship W2043966544A5013997983 @default.
• W2043966544 hasAuthorship W2043966544A5017069200 @default.
• W2043966544 hasAuthorship W2043966544A5017246928 @default.
• W2043966544 hasAuthorship W2043966544A5026925016 @default.
• W2043966544 hasAuthorship W2043966544A5030064179 @default.
• W2043966544 hasAuthorship W2043966544A5034195468 @default.
• W2043966544 hasAuthorship W2043966544A5055132792 @default.
• W2043966544 hasAuthorship W2043966544A5057167506 @default.
• W2043966544 hasAuthorship W2043966544A5070311654 @default.
• W2043966544 hasAuthorship W2043966544A5070621756 @default.
• W2043966544 hasAuthorship W2043966544A5079124490 @default.
• W2043966544 hasBestOaLocation W20439665441 @default.
• W2043966544 hasConcept C126322002 @default.
• W2043966544 hasConcept C141071460 @default.
• W2043966544 hasConcept C155806632 @default.
• W2043966544 hasConcept C2776283816 @default.
• W2043966544 hasConcept C2777546739 @default.
• W2043966544 hasConcept C2781413609 @default.
• W2043966544 hasConcept C2908786992 @default.
• W2043966544 hasConcept C509974204 @default.
• W2043966544 hasConcept C71924100 @default.
• W2043966544 hasConcept C72563966 @default.
• W2043966544 hasConceptScore W2043966544C126322002 @default.
• W2043966544 hasConceptScore W2043966544C141071460 @default.
• W2043966544 hasConceptScore W2043966544C155806632 @default.
• W2043966544 hasConceptScore W2043966544C2776283816 @default.
• W2043966544 hasConceptScore W2043966544C2777546739 @default.
• W2043966544 hasConceptScore W2043966544C2781413609 @default.
• W2043966544 hasConceptScore W2043966544C2908786992 @default.
• W2043966544 hasConceptScore W2043966544C509974204 @default.
• W2043966544 hasConceptScore W2043966544C71924100 @default.
• W2043966544 hasConceptScore W2043966544C72563966 @default.
• W2043966544 hasIssue "8" @default.
• W2043966544 hasLocation W20439665441 @default.
• W2043966544 hasLocation W20439665442 @default.
• W2043966544 hasOpenAccess W2043966544 @default.
• W2043966544 hasPrimaryLocation W20439665441 @default.
• W2043966544 hasRelatedWork W1637986261 @default.
• W2043966544 hasRelatedWork W1973870257 @default.
• W2043966544 hasRelatedWork W2000355459 @default.
• W2043966544 hasRelatedWork W2050702226 @default.
• W2043966544 hasRelatedWork W2065699682 @default.
• W2043966544 hasRelatedWork W2269770147 @default.
• W2043966544 hasRelatedWork W2321681371 @default.

• next